PLx Pharma Obtains $1,297,000 New Funding Round

  • Feed Type
  • Date
    3/11/2016
  • Company Name
    PLx Pharma
  • Mailing Address
    8285 El Rio Houston, TX 77054 USA
  • Company Description
    PLx Pharma is a pharmaceutical company developing the next generation of non-steroidal anti-inflammatory agents (NSAIDs) that are safer on the gut.
  • Website
    http://www.plxpharma.com
  • Transaction Type
    Debt
  • Transaction Amount
    $1,297,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 27 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed